EA
MDT icon

Emerald Acquisition’s Medtronic MDT Stock Holding History

Emerald Acquisition’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$300M Sell
3,469,073
-717,793
-17% -$62.5M 0.58% 21
2016
Q2 		$363M Buy
+4,186,866
New +$339M 0.63% 19

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Emerald Acquisition's MDT Position: Q3 2016 in Review

Emerald Acquisition reduced its Medtronic (MDT) stake by 17% in Q3 2016, selling an estimated $62.5M and leaving 3,469,073 shares worth $300M. The position accounts for 0.58% of the portfolio, ranked #21.

Emerald Acquisition first reported a position in MDT in Q2 2016 and has held it in 2 quarters since. The position peaked at $363M in Q2 2016. 1,266 funds tracked by Wall St. Rank hold MDT as of Q3 2016.

  • Emerald Acquisition held 3,469,073 shares of Medtronic worth $300M as of Q3 2016.
  • Emerald Acquisition sold 717,793 Medtronic shares in Q3 2016, an estimated $62.5M.
  • Medtronic made up 0.58% of Emerald Acquisition's portfolio in Q3 2016, its #21 holding.
  • Emerald Acquisition first reported a position in Medtronic in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Medtronic position peaked at $363M in Q2 2016.
  • 1,266 funds tracked by Wall St. Rank held Medtronic as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.